Few of the record 143 biotech startups that made their public debut last year had a product to sell. We unpack the odd nature of biotech IPOs.
Seed funding
The big global venture capital pullback we all expected is truly here. Venture funding for the third quarter of 2022 fell by 33% quarter over quarter.
Despite the volatility, fear and risk that is coming our way, those very things represent opportunity to keen investors. This cycle has repeated...
What’s the minimum needed to secure pre-seed venture funding? MGV's Marc Schröder shares his thoughts on exactly what pre/seed-stage VCs consider the...
New Enterprise Associates is in the process of closing on its $5.1 billion fund 18, the largest raised by the firm to date.
Scientist and entrepreneur Shawn Carbonell co-founded incubator program Brazen Bio in 2021 to help scientists spin their research out of labs and...
As venture investors and support systems push into the heartland from concentrations on the coasts, some regions are seeing more of a surge. One of...
We set out to explore a different kind of geographic funding analysis. Here’s what we found.
For the second quarter in a row, the Asia venture market declined—following in lock-step what is going on globally.
Global funding slowed dramatically in the second quarter of 2022 as investors shied away from later-stage funding bets. It also marked the first...
Peterson Ventures, an investor at the seed stage, has closed on a total of $140 million for its fourth fund as well as its first opportunity fund.
Featured
CTA
Find the right companies, identify the right contacts, and connect with decision-makers with an all-in-one prospecting solution.
67.1K Followers